Patient experiences of receiving a diagnosis of hypermobile Ehlers–Danlos syndrome
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63613 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Yun-Ting Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Ehlers-Danlos Syndrome, Quality of Life. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Hypermobile Ehlers–Danlos syndrome (hEDS) presents with a wide range of clinical symptoms and comorbidities that impact quality of life. The diagnosis is challenging and often delayed due to the heterogeneity of the disease and lack of diagnostic biomarkers, which adds to the disease burden by affecting patients' psychosocial adaptation and overall well‐being. Previous studies have revealed that healthcare professionals and the public have a limited understanding and familiarity with the condition, which leads to disapproval and skepticism that greatly impact patients' social spheres and welfare. While physical manifestations have been widely discussed, the psychosocial impact and the importance of receiving a diagnosis have not been fully studied in the current literature. This survey study investigated the impact of diagnosis in hEDS patients, selected from the University of Miami's hEDS registry. Survey questions were formulated based on clinical expertise and literature review. Descriptive statistics, Mann–Whitney test, and Spearman's correlation were used for data analysis. The median age at symptom presentation was 10 years, with a median gap of 4 years before the initial medical evaluation. On average, it took 10 years to receive a diagnosis of hEDS. Nearly all participants (95.2%) expressed receiving a diagnosis as “important” or “highly important,” with 81.9% agreeing that it helped them cope with their condition better, 76.8% could better manage their symptoms, and felt more in control of their long‐term care. Participants mostly had a positive emotional reaction and experienced an improvement in the support they were receiving from their caregivers and healthcare providers after receiving a diagnosis of hEDS. This study demonstrates that receiving a diagnosis could positively impact the patient's support, quality of care, and overall well‐being.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA.
- Department of learning sciences and educational Research, University of Central Florida, Orlando, Florida, USA.
- Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida, USA.
- Department of Oncology, Division of Clinical Genetics, Mount Sinai Medical Center at Florida, Miami, Florida, USA.
Zitieren
APA
Wang, Y. T., Jahani, S., Morel-Swols, D., Kapely, A., Rosen, A., & Forghani, I. (2024). Patient experiences of receiving a diagnosis of hypermobile Ehlers–Danlos syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63613
Vancouver
Wang YT, Jahani S, Morel-Swols D, Kapely A, Rosen A, Forghani I. Patient experiences of receiving a diagnosis of hypermobile Ehlers–Danlos syndrome. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63613
BibTeX
@article{Wang2024,
author = {Wang, Yun-Ting and Jahani, Shiva and Morel-Swols, Dayna and Kapely, Angelica and Rosen, Ami and Forghani, Irman},
title = {Patient experiences of receiving a diagnosis of hypermobile Ehlers–Danlos syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63613}
}
EUVIMED